The AIM-listed firm said Fruitflow+ Omega-3 is a two-in-one supplement in an easy to take capsule, supporting healthy blood flow and normal heart function.
The product will be listed in August 2018 in more than 660 Holland & Barrett stores across the UK and Ireland, together with Holland & Barrett Online, giving widespread consumer exposure to the product and the company.
Provexis said Holland & Barrett staff will be trained to understand and communicate the benefits of Fruitflow+ Omega-3 to prospective customers in-store and online.
Dawson Buck, chairman of Provexis, said: “The listing will help raise awareness of the proven benefits of Fruitflow across a substantial consumer audience, and the company's expanding Fruitflow + dietary supplement business is expected to provide the company with an additional long-term income and profit stream.”
He added: “We look forward to working with Holland & Barrett to maximise recommendation, trial and repeat purchase of the product.”
In lunchtime trading, Provexis shares jumped 12.5% to 0.45p.